The global intra-abdominal pressure measurement devices market is expected to reach a valuation of US$ 98.9 million in 2023 and further expand at a CAGR of 12.40% during the forecast period, totaling around US$ 318.3 million by 2033.
The increasing prevalence of intra-abdominal hypertension and abdominal compartment syndrome drives market demand for intra-abdominal pressure measurement devices.
Patients in intensive care units (ICUs) all over the world frequently suffer from abdominal compartment syndrome (ACS) and intra-abdominal hypertension (IAH). The risk of ACS and IAH is evaluated using the intra-abdominal pressure measurement device. It is a key reason fuelling the intra-abdominal pressure measurement devices market growth.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rise in Intra-abdominal Hypertension and Advancement in Intra-abdominal Pressure Measuring Devices to Bolster Market Growth
Because intra-abdominal hypertension is becoming more common among patients in intensive care units worldwide, the demand for intra-abdominal pressure monitoring devices is projected to rise over the forecast period.
Nowadays, digital intra-abdominal pressure monitoring devices are often used in the ICU to constantly monitor patients who do not need doctors to monitor them. Hence, the digitalization of intra-abdominal pressure monitoring devices is estimated to boost the growth of the intra-abdominal pressure measurement devices market.
Similarly, the demand for compartment syndrome measurement devices is anticipated to grow shortly due to the growing availability and use of innovative instruments such as digital pressure monitors.
In addition, rising ICU admissions due to traumatic injuries and the increasing prevalence of chronic diseases in developing nations are key factors promoting market expansion.
The high risk of complications associated with intra-abdominal pressure measuring procedures is a key factor restraining the market's growth.
The bladder is often used to monitor intra-abdominal pressure in patients. Bladder infections and needle stick wounds are two significant issues with pressure management devices that could put patients at risk and cause discomfort.
Complicated surgical procedures may result in an elevation of the locations, and adhesion may produce false results regarding the patient's conditions, hindering the market growth for intra-abdominal pressure measurement devices. There are issues regarding the infusion volume, indications, measurement frequency, and zero-reference point while monitoring the patient. Such conditions are anticipated to impede market expansion.
Attributes | Details |
---|---|
Market CAGR (2023 to 2033) | 12.40% |
Market Valuation (2023) | US$ 98.9 million |
Market Valuation (2033) | US$ 318.3 million |
The global sales of intra-abdominal pressure management devices are projected to rise at an impressive CAGR of 12.40% between 2023 and 2033, compared to a 10.6% CAGR registered from 2018 to 2022. The market secured a valuation of US$ 54 million in 2018 and US$ 89.4 million in 2022.
In critically ill patients, abdominal compartment syndrome (ACS) and intra-abdominal hypertension (IAH) are recognized causes of morbidity and mortality. As a result, monitoring and measuring them becomes essential. For this purpose, intra-abdominal pressure measurement devices are being used.
Intra-abdominal pressure variations can occur in various medical situations, including hepatorenal syndrome, large-volume resuscitation, acute decompensated heart failure, and acute and sepsis pancreatitis, among several other indications.
Globally, there is rising concern over the prevalence of intra-abdominal hypertension (IAH). The escalating prevalence of IAH and ACS cases in both established and developing countries has also encouraged the introduction of technologically advanced devices into the market for intra-abdominal pressure measurement, which is estimated to boost market sales during the forecast period.
Since intra-abdominal hypertension is more common in critically ill patients, all patients in the ICU should have their intra-abdominal pressure monitored during the first few days. It has led to an upsurge in global sales of devices that monitor intra-abdominal pressure.
IAH and ACS in children are more likely to happen in cases of intra-peritoneal ascites, severe gut edema, and key fluid resuscitation. As a result, there is an increased demand for intra-abdominal pressure measurement devices for monitoring children, and this aspect is estimated to further support the market expansion for these devices throughout the upcoming years.
Demand to Remain High for Disposables in the Market
Based on product, the disposables segment held a substantial share of around 89.8% in the global market in 2023. It is projected to expand at a CAGR of about 12.5% throughout the forecast period. It can be attributed to the rising application of disposable devices for real-time intra-abdominal pressure monitoring.
Disposable monitoring tools establish a clinically accurate monitoring system that is standardized, effective, and safe. Measurements may be taken with this tool in just a few minutes. Thus, disposable products' rapid and effective utilization for measuring intra-abdominal pressure is estimated to fuel market growth through increased adoption over the forecast years.
Adoption Remains High for Measuring Intra-abdominal Hypertension
By application, the intra-abdominal hypertension segment held the highest market share of about 86.5% in the global market in 2023. It is further expected to accelerate at a CAGR of 12.7% from 2023 to 2033.
The high market share of this segment is due to the rising prevalence of intra-abdominal hypertension and the increasing usage of intra-abdominal pressure measurement devices for measuring IAH.
Intensive care unit (ICU) patients may suffer from intra-abdominal hypertension (IAH), which is becoming more widely recognized as a potential complication. IAH impacts all body systems, although the respiratory, nervous, cardiovascular, and renal systems are likely to be affected.
The Majority of Sales is to Remain Concentrated in Hospitals
The hospital segment held a higher market share value of around 73.7% in 2023, likely generating huge revenues during the forecast period. It can be attributed to the high prevalence of disease, advanced medical equipment, and the availability of skilled professionals.
Similarly, rising patient inclination towards opting for hospital treatments to reduce overall costs is estimated to generate demand for intra-abdominal pressure measurement devices across hospitals.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Countries | Forecast Value Share Between 2023 to 2033 |
---|---|
United States | 45.1% |
Germany | 6.7% |
Japan | 6.4% |
Countries | Forecast CAGR Between 2023 to 2033 |
---|---|
China | 16.0% |
India | 18.40% |
Australia | 15.70% |
United Kingdom | 11.40% |
Rapid Expansion of Healthcare Infrastructure To Boost Market Growth in the United States
As per FMI, the United States held around 45.1% share in the global market with a CAGR of 10.5% during the forecast period.
The rapid rise in hospitals and ambulatory surgical centers, the adoption of advanced medical technologies, and the surge in cases of chronic diseases are some key factors driving growth in the United States market.
According to the American Hospital Association (AHA), the total count of hospitals in the United States reached 6,093 in 2020, and this number is further expected to surge during the forthcoming years.
Similarly, growth in blunt abdominal trauma cases due to road accidents and increasing investments in research and development activities are expected to push the demand for intra-abdominal pressure measurement devices.
In addition, rising government initiatives and the heavy presence of leading manufacturers are estimated to support the expansion of the industry in the United States during the forthcoming years.
Easy Availability of Products at Much Lower Prices Fuelling Demand in China's Market
With around 40.8% share with a CAGR of 16.0%, China is significantly driving the global market during the forecast period.
Factors such as the rising prevalence of chronic disease, availability of medical devices at much lower prices, and surge in the export of medical devices are some key factors driving China's market.
Players in the global market have recently relied on Chinese suppliers to supply key equipment components. By offering items at relatively lower rates, these Chinese players are putting further pressure on their Western competitors to lower the pricing of their components and products.
Furthermore, Chinese key players supply raw materials, which are used for manufacturing intra-abdominal pressure measurement devices, at a lower cost, and this factor is estimated to boost the market expansion over the projected years.
Rise in Medical Tourism to Boost Sales in the United Kingdom Market
The United Kingdom held around 21.1% of the global market in 2023. It is projected to grow robustly during the next ten years, making it one of the most likely lucrative markets across Europe. The United States is estimated to register a CAGR of 11.40% in the global market by 2033.
The increasing risk of injuries in the geriatric population, the high prevalence of chronic diseases, and flourishing medical tourism are some factors driving the United Kingdom's intra-abdominal pressure measurement devices market.
Similarly, improvements in treatment protocols, demand for better diagnostics, and the preference for preventative abdominal decompression treatments for trauma management are estimated to all have a favorable effect on the country's market.
The market is highly fragmented, with several competitors in the intra-abdominal pressure measurement devices space. These companies are implementing mergers and acquisitions, partnerships and collaborations, and new product launches to meet consumer demand and expand their customer base.
Other Prominent Players in the Global Market are:
Instances of key developmental strategies by the industry players in the global market are given below:
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | US$ billion for Value |
Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
Key Segments Covered | Product, Application, End User, Region |
Key Companies Profiled | C.R. Bard, Inc.; ConvaTec Group PLC; Stryker Corporation; Biometrix Ltd. (Degania Silicone, Ltd.); Centurion Medical Products; Holtech Medical; ConvaTec Group PLC; Potrero Medical; Gaeltec Devises Ltd.; Speigelberg GmbH & Co. KG.; C2Dx Inc.; Scranton Gillette Communication; Nutrimedics S.A.; SEM Mthembu Medical (Pty) Ltd; Carl Zeiss AG |
Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
The intra-abdominal pressure measurement devices market is predicted to expand at a 12.40% CAGR through 2033.
The hospital sector drives the intra-abdominal pressure measurement devices market.
The intra-abdominal pressure measurement devices market is expected to surpass US$ 318.3 million by 2033.
The intra-abdominal pressure measurement devices market is anticipated to be US$ 98.9 million in 2023.
The United States is dominating the global intra-abdominal pressure measurement devices market by 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Disposables
5.3.2. Equipment
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Intra-abdominal Hypertension
6.3.2. Intra-compartment Pressure
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Trauma Centers
7.3.4. Ambulatory Surgical Centers (ASCs)
7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product
14.2.3. By Application
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Application
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product
16.1.2.2. By Application
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product
16.2.2.2. By Application
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product
16.3.2.2. By Application
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product
16.4.2.2. By Application
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product
16.5.2.2. By Application
16.5.2.3. By End User
16.6. U.K.
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product
16.6.2.2. By Application
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product
16.7.2.2. By Application
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product
16.8.2.2. By Application
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product
16.9.2.2. By Application
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product
16.10.2.2. By Application
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product
16.11.2.2. By Application
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product
16.12.2.2. By Application
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product
16.13.2.2. By Application
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product
16.14.2.2. By Application
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product
16.15.2.2. By Application
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product
16.16.2.2. By Application
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product
16.17.2.2. By Application
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product
16.18.2.2. By Application
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product
16.19.2.2. By Application
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product
16.20.2.2. By Application
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product
16.21.2.2. By Application
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product
16.22.2.2. By Application
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Product
16.23.2.2. By Application
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. C.R. Bard, Inc.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. ConvaTec Group PLC
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Stryker Corporation
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Biometrix Ltd. (Degania Silicone, Ltd.)
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Centurion Medical Products
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Holtech Medical
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. ConvaTec Group PLC
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Potrero Medical
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Gaeltec Devises Ltd.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Speigelberg GmbH & Co. KG.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
18.1.11. C2Dx Inc.
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.11.5.2. Product Strategy
18.1.11.5.3. Channel Strategy
18.1.12. Scranton Gillette Communication
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.12.5.2. Product Strategy
18.1.12.5.3. Channel Strategy
18.1.13. Nutrimedics S.A.
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.13.5.2. Product Strategy
18.1.13.5.3. Channel Strategy
18.1.14. SEM Mthembu Medical (Pty) Ltd
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
18.1.14.5.2. Product Strategy
18.1.14.5.3. Channel Strategy
18.1.15. Carl Zeiss AG
18.1.15.1. Overview
18.1.15.2. Product Portfolio
18.1.15.3. Profitability by Market Segments
18.1.15.4. Sales Footprint
18.1.15.5. Strategy Overview
18.1.15.5.1. Marketing Strategy
18.1.15.5.2. Product Strategy
18.1.15.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports